Research Topics
| Gary Y YangSummaryAffiliation: Roswell Park Cancer Institute Country: USA Publications
| Collaborators
|
Detail Information
Publications
Multimodality approaches for pancreatic cancerGary Y Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
CA Cancer J Clin 55:352-67. 2005..Our aim is to summarize the current state-of-the-art management and future directions regarding the multimodality approach to pancreatic cancer...
Renal atrophy secondary to chemoradiotherapy of abdominal malignanciesGary Y Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
Int J Radiat Oncol Biol Phys 78:539-46. 2010..To identify factors predictive of renal atrophy after chemoradiotherapy of gastrointestinal malignancies...- Long-term outcome of stage I seminomaGary Y Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
Am J Clin Oncol 30:205-10. 2007..To report on long-term outcomes among patients with stage I seminoma treated by orchiectomy with or without adjuvant radiation... - Misrepresentation of publications among radiation oncology residency applicantsGary Y Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
J Am Coll Radiol 3:259-64. 2006..Authorship misrepresentations have been described for residency and fellowship applications for various medical specialties. This study assessed the prevalence of misrepresented publications in radiation oncology residency applications... - Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinomaMarwan G Fakih
Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
Int J Radiat Oncol Biol Phys 72:650-7. 2008..To evaluate the efficacy of a combination of capecitabine, oxaliplatin, and radiotherapy (RT) in the neoadjuvant treatment of Stage II and III rectal cancers... - Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomenKilian Salerno May
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
Int J Radiat Oncol Biol Phys 76:1193-8. 2010..To analyze clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen... 
Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignanciesKilian Salerno May
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
J Gastrointest Oncol 1:7-15. 2010..This study evaluated the association between renal function as measured by biochemical endpoints and scintigraphy and dose volume parameters in patients with gastrointestinal malignancies...- Palliation of malignant dysphagia in esophageal cancer: a literature-based reviewMilind Javle
Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo, New York 14263, USA
J Support Oncol 4:365-73, 379. 2006..The benefits and disadvantages of these approaches along with a concise review of the literature are presented... - Cancer immunotherapy and heat-shock proteins: promises and challengesMasoud H Manjili
Department of Cellular Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
Expert Opin Biol Ther 4:363-73. 2004..These points should also clarify the conflicting findings about HSPs and promote our knowledge about other immuologically important components that may be present in HSP preparations... - A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinomaMarwan G Fakih
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
Int J Radiat Oncol Biol Phys 65:1462-70. 2006..We conducted a Phase I study to determine the maximum tolerated dose (MTD) of neoadjuvant capecitabine, oxaliplatin, and radiation therapy (RT) in Stage II to III rectal adenocarcinoma... - The role of radiation in the perioperative treatment of esophagogastric cancerKilian S May
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
Curr Treat Options Oncol 12:61-71. 2011..The current generation of clinical trials in this heterogeneous group of diseases is examining targeted therapy, newer methods of radiotherapy, and predictors of response to therapy aiming to tailor management to an individual patient... - The role of positron emission tomography in esophageal cancerGary Y Yang
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
Gastrointest Cancer Res 2:3-9. 2008..In addition, FDG-PET has also been shown to have prognostic value that can be applied to patient management and aid in development of emerging therapies... - FDG PET imaging in the staging and management of gastric cancerShane Hopkins
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
J Gastrointest Oncol 2:39-44. 2011..New criteria have been proposed establishing response metrics in the utilization of PET. More study is needed to support these criteria in routine practice and establish the place of PET in the staging and management of gastric cancer... - Benefits and challenges of radiation therapy in gastric cancer: techniques for improving outcomesSusan A McCloskey
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY
Gastrointest Cancer Res 3:15-9. 2009..The practicing clinician is urged to draw upon the multitude of resources now available to ensure that optimal RT for gastric cancer is delivered safely and accurately... - Positron emission tomography as predictor of rectal cancer response during or following neoadjuvant chemoradiationShane Hopkins
Shane Hopkins, Gary Y Yang, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, United States
World J Gastrointest Oncol 2:213-7. 2010..Finding the best evaluation interval and parameters to use for interpreting PET results in the neo-adjuvant treatment of rectal cancer needs additional study... - Cetuximab: its use in combination with radiation therapy and chemo-therapy in the multimodality treatment of head and neck cancerTimothy D Wagner
Department of Radiology, Radiation Oncology Service, Brooke Army Medical Center, Fort Sam Houston, Texas, USA
Recent Pat Anticancer Drug Discov 3:76-83. 2008..In this manuscript, the mechanism of cetuximab with its associated patents is reviewed, with its role with chemotherapy and radiation in the management of head and neck cancer along with future directions of this targeted cancer therapy... - Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancerSikander Ailawadhi
Department of Internal Medicine, State University of New York at Buffalo, USA
Oncology 70:49-53. 2006..None of the CEA surges satisfied the American Society of Clinical Oncology definition of CEA progression. A rise in CEA after initiation of chemotherapy, unless lasting >4 months, cannot be used as an indicator of progressive disease... - Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicityJerome C Landry
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
Med Dosim 27:121-9. 2002..IMRT with an inverse treatment plan has the potential to significantly improve radiation therapy of pancreatic cancers by reducing normal tissue dose, and simultaneously allow escalation of dose to further enhance locoregional control...